Lv21
158 积分 2023-10-31 加入
Discovery of Novel Small Molecule Inhibitors Disrupting the PCSK9-LDLR Interaction
30天前
已完结
PocketFlow is a data-and-knowledge-driven structure-based molecular generative model
1个月前
已完结
Creating an AI-first drug discovery engine
2个月前
已完结
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
2个月前
已完结
Rat cathepsin K: Enzymatic specificity and regulation of its collagenolytic activity
2个月前
已关闭
Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins
2个月前
已完结
Extending the Structural View of Class B GPCRs
5个月前
已完结
Surface Plasmon Resonance Screening to Identify Active and Selective Adenosine Receptor Binding Fragments
9个月前
已完结
C-Terminal Modifications of Apelin-13 Significantly Change Ligand Binding, Receptor Signaling, and Hypotensive Action
10个月前
已完结
The Structure–property Relationships of GPCR-targeted Drugs Approved between 2011 and 2021
10个月前
已完结
皖公网安备34019202002308
